Nuzenio

Tradingview Arwr

Tradingview Arwr entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

ARWR: Positive SHTG phase III data and REDEMPLO launch momentum drive revenue and pipeline progress - TradingViewTradingView · Tue, 04 Aug 2026 22:58:39 GMTARWR: Positive SHTG data, accelerating REDEMPLO launch, and robust pipeline drive growth outlook - TradingViewTradingView · Tue, 04 Aug 2026 22:18:53 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:56 GMTArrowhead reports Q3 FY2026 revenue $75.3M, net loss $194.3M, strong REDEMPLO and plozasiran progress - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTARWR: Revenue up, net loss widened; REDEMPLO and pipeline achieved major clinical and commercial milestones - TradingViewTradingView · Tue, 04 Aug 2026 20:11:01 GMTArrowhead Pharmaceuticals Q3 revenue jumps on REDEMPLO growth - TradingViewTradingView · Tue, 04 Aug 2026 20:10:54 GMTARWR: Quarterly revenue surged on new deals and REDEMPLO sales, but losses widened due to higher R&D and SG&A - TradingViewTradingView · Tue, 04 Aug 2026 20:10:27 GMTARWR Q3'26 Earnings: EPS estimate is (1.28) USD - TradingViewTradingView · Mon, 03 Aug 2026 11:00:32 GMT

Timeline

Tue, 04 Aug 2026 22:58:39 GMTARWR: Positive SHTG phase III data and REDEMPLO launch momentum drive revenue and pipeline progress - TradingView
Tue, 04 Aug 2026 22:18:53 GMTARWR: Positive SHTG data, accelerating REDEMPLO launch, and robust pipeline drive growth outlook - TradingView
Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingView
Tue, 04 Aug 2026 20:13:01 GMTArrowhead reports Q3 FY2026 revenue $75.3M, net loss $194.3M, strong REDEMPLO and plozasiran progress - TradingView
Tue, 04 Aug 2026 20:11:01 GMTARWR: Revenue up, net loss widened; REDEMPLO and pipeline achieved major clinical and commercial milestones - TradingView
Tue, 04 Aug 2026 20:10:54 GMTArrowhead Pharmaceuticals Q3 revenue jumps on REDEMPLO growth - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Arwr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.